CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	3 Months Ended
	Jun. 30, 2016	Jun. 30, 2015
Cash flows from operating activities:
Net loss	$ (1,967,100)	$ (29,524,100)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	13,300	14,500
Amortization of discounts on convertible and promissory notes	0	550,800
Change in warrant liability	0	1,894,700
Stock-based compensation	107,900	29,200
Expense related to modification of warrants, including exchange of warrants for Series C Preferred and common stock	40,300	122,300
Amortization of deferred rent	(7,900)	(4,700)
Fair value of common stock granted for services	0	500,000
Fair value of Series B Preferred stock granted for services	375,000	250,000
Loss on currency fluctuation	0	10,300
Loss on extinguishment of debt	0	25,050,900
Changes in operating assets and liabilities:
Prepaid expenses and other current assets	34,600	(8,200)
Accounts payable and accrued expenses, including accrued interest	(267,100)	291,000
Net cash used in operating activities	(1,671,000)	(823,300)
Cash flows from investing activities:
Purchases of equipment	(2,000)	0
Net cash used in investing activities	(2,000)	0
Cash flows from financing activities:
Net proceeds from issuance of common stock and warrants, including Units	9,537,100	280,000
Net proceeds from issuance of Series B Preferred Units	278,000	607,500
Repayment of capital lease obligations	(300)	(200)
Repayment of notes	(70,400)	(13,000)
Net cash provided by financing activities	9,744,400	874,300
Net increase in cash and cash equivalents	8,071,400	51,000
Cash and cash equivalents at beginning of period	428,500	70,000
Cash and cash equivalents at end of period	8,499,900	121,000
Supplemental disclosure of noncash activites:
Conversion of Senior Secured Notes, Subordinate Convertible Notes, Promissory Notes, Accounts payable and other debt into Series B Preferred	0	17,335,400
Insurance premiums settled by issuing note payable	117,500	79,400
Accrued dividends on Series B Preferred	539,000	213,300
Accrued dividends on Series B Preferred settled upon conversion by issuance of common stock	$ 1,683,400	$ 0